Longevity medicine mainstreaming: tesamorelin fits squarely into the longevity conversation, where visceral fat reduction and cognitive preservation are both high-priority outcomes
He often turned to his PowerPoint presentations to explain the science
Duvyzat won approval on the strength of a Phase III study that met the primary endpoint of a change in the four-stair climb assessment from the baseline to 72 weeks and showed favorable outcomes in key secondary measures, according to Italfarmaco
Notably, this comes as the FDA introduced a so-called Green List in September 2025: a mechanism aimed at preventing potentially unsafe active pharmaceutical ingredients (APIs) from unverified foreign sources, particularly those for GLP-1 drugs, from entering the U.S
Start your intake How to Access Oral Semaglutide Without Insurance Traditional pharmacy channels require insurance approval, specialty pharmacy referrals, and often deny coverage for weight loss indications
